The proliferation of CD4+ T cells in prostate cancer patients before seed implantation was significantly higher than in healthy controls (3.80% mean with 1.61–6.00 95% CI proliferating CD4+ cells in cancer patients versus 1.36% mean with 0.78–1.93% 95% CI in healthy controls). The gene discussed is CD4; the disease is prostate cancer.